Catalyst Wire Dossier Catalyst Wire Dossier

MY006

· Mabylon AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MY006, covering 2025-12-30 to 2025-12-30. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy [Phase 1]

See pricing